Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801

Experimental Neurology
Geanne M A CunhaRodrigo A Cunha

Abstract

Adenosine A2A receptor antagonists alleviate memory deficits caused by aging or by administration of beta-amyloid peptides in rodents, which is in accordance with the beneficial effects of caffeine consumption (an adenosine receptor antagonist) on memory performance in aged individuals and in preventing Alzheimer's disease. We now tested if A2A receptor blockade affords a general beneficial effect in different experimental paradigms disturbing memory performance in rodents. The beta-amyloid fragment present in patients with Alzheimer's disease (Abeta1-42, 2 nmol, icv) decreased spontaneous alternation in the Y-maze after 15 days (29%) to an extent similar to the decrease of memory performance caused by scopolamine (2 mg/kg, ip) or MK-801 (0.25 mg/kg, ip) after 30 min (28% and 39%, respectively). The selective A2A receptor antagonist SCH58261 (0.05 mg/kg, ip every 24 h, starting 30 min before the noxious stimuli) prevented Abeta1-42-induced amnesia, but failed to modify scopolamine- or MK-801-induced amnesia. Similar conclusions were reached when testing another A2A receptor antagonist (KW6002, 3 mg/kg, ip). These results indicate that A2A receptors do not affect general processes of memory impairment but instead play a crucial ...Continue Reading

References

Jul 1, 1975·Pharmacology, Biochemistry, and Behavior·H Anisman
Feb 1, 1996·Psychopharmacology·N HooperT W Stone
Dec 1, 1995·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M PitkänenP Riekkinen
Jul 9, 2002·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L Maia, A de Mendonça
Oct 25, 2002·American Journal of Epidemiology·Marilyn Johnson-KozlowDeborah Morton
Jan 13, 2004·Physiological Reviews·M A Lynch
Jun 16, 2004·Parkinsonism & Related Disorders·Sergi FerréAmina Woods
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·Bertil B FredholmJean-Marie Vaugeois
Mar 8, 2006·Experimental Neurology·Jian Hong WangMaarten van den Buuse
Jul 11, 2006·Neurobiology of Learning and Memory·Lydia Giménez-LlortMichael Bader
Oct 3, 2006·Current Opinion in Neurobiology·Michael E Hasselmo
Oct 13, 2006·Trends in Neurosciences·Michael A SchwarzschildMicaela Morelli
Jul 25, 2007·Progress in Neurobiology·S N SchiffmannS Ferré
Nov 6, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Reinaldo Naoto TakahashiRui Daniel Schroder Prediger

❮ Previous
Next ❯

Citations

Feb 22, 2011·Psychopharmacology·Inge Klinkenberg, Arjan Blokland
Jan 21, 2011·Nature Reviews. Neuroscience·Amantha Thathiah, Bart De Strooper
Dec 10, 2014·Neurobiology of Learning and Memory·Josiane Woutheres BortolottoCarla Denise Bonan
Aug 8, 2013·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Ya-Lei NingYuan-Guo Zhou
Mar 22, 2014·Biochemical Society Transactions·Vanessa FlatenDavid Blum
Jun 23, 2011·Pharmacology, Biochemistry, and Behavior·Renata Viana AbreuTasso Moraes-Santos
Jan 20, 2018·Contrast Media & Molecular Imaging·Anna VuorimaaLaura Airas
Feb 9, 2018·Neurochemical Research·Simonetta CamandolaMark P Mattson
Dec 3, 2008·The European Journal of Neuroscience·Alexandra L Ferguson, Trevor W Stone
Jul 30, 2010·Journal of Neurochemistry·Sandra P BuiraMarta Barrachina
Jul 17, 2019·Current Pharmaceutical Design·Hira ChoudhuryBapi Gorain
Oct 9, 2019·Journal of Alzheimer's Disease : JAD·Ahmed Morsy, Paul C Trippier
Feb 13, 2020·Pharmacological Reports : PR·Samane HeydariAli Rezaei Mokarram
Jul 2, 2016·Journal of Neurochemistry·Rodrigo A Cunha
May 6, 2015·British Journal of Pharmacology·N PagnussatL O Porciúncula
Aug 21, 2018·Frontiers in Neuroscience·Lucrezia CellaiVictoria Gomez-Murcia
Jul 10, 2019·Current Topics in Medicinal Chemistry·Jindian LiKai Chen
May 14, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yuri ParkYoung G Shin
Feb 11, 2021·Nutrients·Piotr LondzinJoanna Folwarczna
Sep 25, 2017·Neurobiology of Aging·Emrin Horgusluoglu-MolochUNKNOWN Alzheimer's Disease Neuroimaging Initiative (ADNI)
Dec 15, 2010·Biochimica Et Biophysica Acta·Catarina V GomesRodrigo A Cunha
Jun 1, 2021·Frontiers in Neuroscience·Cátia R LopesPaula Agostinho
Feb 15, 2011·Neuropharmacology·Detlev BoisonBenjamin K Yee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.